Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hazel M Dockrell

Showing results (101-110 of 142) with videos related to

Pageof 15
Sort By:
Memorias Do Instituto Oswaldo Cruz|January 4, 2013
Identification of serological biomarkers of infection, disease progression and treatment efficacy for leprosyJohn S Spencer, Malcolm S Duthie, Annemieke Geluk, et al.
Frontiers in Immunology|August 28, 2020
Mitochondrial Signature in Human Monocytes and Resistance to Infection in <i>C. elegans</i> During Fumarate-Induced Innate Immune TrainingC Angélica Pérez-Hernández, Carina C Kern, Egle Butkeviciute, et al.
Clinical and Vaccine Immunology : CVI|August 30, 2013
Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCGHelen A Fletcher, Rachel Tanner, Robert S Wallis, et al.
BMC Genomics|February 23, 2020
Whole genome sequencing of Mycobacterium tuberculosis isolates and clinical outcomes of patients treated for multidrug-resistant tuberculosis in TanzaniaBugwesa Z Katale, Peter M Mbelele, Nsiande A Lema, et al.
Frontiers in Immunology|March 15, 2021
Evaluation of Host Serum Protein Biomarkers of Tuberculosis in sub-Saharan AfricaThomas C Morris, Clive J Hoggart, Novel N Chegou, et al.
Vaccine|January 18, 2006
The PPD-specific T-cell clonal response in UK and Malawian subjects following BCG vaccination: a new repertoire evolves over 12 monthsAndrea R Bennett, Patricia Gorak-Stolinska, Anne Ben-Smith, et al.
Frontiers in Immunology|June 2, 2020
Maternal Latent <i>Mycobacterium tuberculosis</i> Does Not Affect the Infant Immune Response Following BCG at Birth: An Observational Longitudinal Study in UgandaLawrence Lubyayi, Patrice A Mawa, Grace Nabakooza, et al.
Lancet (London, England)|April 30, 2002
BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studiesGillian F Black, Rosemary E Weir, Sian Floyd, et al.
Infection and Immunity|February 24, 2004
Mycobacterial purified protein derivatives stimulate innate immunity: Malawians show enhanced tumor necrosis factor alpha, interleukin-1beta (IL-1beta), and IL-10 responses compared to those of adolescents in the United KingdomRosemary E Weir, Gillian F Black, Hazel M Dockrell, et al.
Vaccines|January 8, 2025
Boosting Vaccine Research: The 16-Year Journey of TRANSVAC Vaccine InfrastructureWilliam Martin, Catarina Luís, Stefan Jungbluth, et al.
Pageof 15

Showing results (101-110 of 142) with videos related to

Sort By:
Pageof 15
Memorias Do Instituto Oswaldo Cruz|January 4, 2013
Identification of serological biomarkers of infection, disease progression and treatment efficacy for leprosyJohn S Spencer, Malcolm S Duthie, Annemieke Geluk, et al.
Frontiers in Immunology|August 28, 2020
Mitochondrial Signature in Human Monocytes and Resistance to Infection in <i>C. elegans</i> During Fumarate-Induced Innate Immune TrainingC Angélica Pérez-Hernández, Carina C Kern, Egle Butkeviciute, et al.
Clinical and Vaccine Immunology : CVI|August 30, 2013
Inhibition of mycobacterial growth in vitro following primary but not secondary vaccination with Mycobacterium bovis BCGHelen A Fletcher, Rachel Tanner, Robert S Wallis, et al.
BMC Genomics|February 23, 2020
Whole genome sequencing of Mycobacterium tuberculosis isolates and clinical outcomes of patients treated for multidrug-resistant tuberculosis in TanzaniaBugwesa Z Katale, Peter M Mbelele, Nsiande A Lema, et al.
Frontiers in Immunology|March 15, 2021
Evaluation of Host Serum Protein Biomarkers of Tuberculosis in sub-Saharan AfricaThomas C Morris, Clive J Hoggart, Novel N Chegou, et al.
Vaccine|January 18, 2006
The PPD-specific T-cell clonal response in UK and Malawian subjects following BCG vaccination: a new repertoire evolves over 12 monthsAndrea R Bennett, Patricia Gorak-Stolinska, Anne Ben-Smith, et al.
Frontiers in Immunology|June 2, 2020
Maternal Latent <i>Mycobacterium tuberculosis</i> Does Not Affect the Infant Immune Response Following BCG at Birth: An Observational Longitudinal Study in UgandaLawrence Lubyayi, Patrice A Mawa, Grace Nabakooza, et al.
Lancet (London, England)|April 30, 2002
BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studiesGillian F Black, Rosemary E Weir, Sian Floyd, et al.
Infection and Immunity|February 24, 2004
Mycobacterial purified protein derivatives stimulate innate immunity: Malawians show enhanced tumor necrosis factor alpha, interleukin-1beta (IL-1beta), and IL-10 responses compared to those of adolescents in the United KingdomRosemary E Weir, Gillian F Black, Hazel M Dockrell, et al.
Vaccines|January 8, 2025
Boosting Vaccine Research: The 16-Year Journey of TRANSVAC Vaccine InfrastructureWilliam Martin, Catarina Luís, Stefan Jungbluth, et al.
Pageof 15